MTOR and cancer: mTOR inhibitors, such as sirolimus, everolimus, and temsirolimus, which are approved or in the clinical stages for cancer treatment, can inhibit the mTOR signaling pathway and inhibit the development of cancer cells into invasive types of cancer [66].